Hazal Eken
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hazal Eken has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Nurcan Bektas
Anadolu University
5 shared publications - Rana Arslan
Department of Pharmacology Faculty of Pharmacy Anadolu University Eskisehir Turkey
3 shared publications - Feyza Alyu Altınok
Anadolu University
2 shared publications - Rana Arslan
Anadolu University Faculty of Pharmacy, Department of Pharmacology, 26470 Eskisehir, Turkey
2 shared publications - Behiye Şenel
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey
1 shared publication Berkant Kurban
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Türkiye; Department of Pharmaceutical Chemistry, Graduate School, Anadolu University, Eskişehir 26470, Türkiye
1 shared publication
Latest Publications
- 12 May 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (5) , e01995
In Vivo Evaluation of the Analgesic Effects of Orientin With Possible Underlying Mechanisms
Orientin is a water‐soluble flavonoid C‐glycoside present in various medicinal plants and known for its diverse pharmacological activities. The present study aimed to evaluate the acute antinociceptive effects of orientin and to investigate the involvement of adrenergic, opioidergic, cannabinoid systems, and ATP‐sensitive potassium channels in these effects. Orientin (50, 100, and 200 mg/kg, i.p.) was administered to mice. Central antinociceptive activity was assessed using the hot‐plate and tail‐immersion tests, while peripheral activity was evaluated using the acetic acid‐induced writhing test. To explore the underlying mechanisms, mice were pretreated with yohimbine (α2‐adrenoceptor antagonist), naloxone (μ‐opioid receptor antagonist), AM251 (CB1 receptor antagonist), AM630 (CB2 receptor antagonist), or glibenclamide (KATP channel blocker) prior to orientin administration. Orientin significantly reduced nociceptive responses in all experimental models at the tested doses. All antagonists except glibenclamide significantly reversed the spinal, supraspinal, and peripheral antinociceptive effects of orientin to varying degrees. These findings suggest that α2‐adrenoceptors, μ‐opioid receptors, and cannabinoid CB1 and CB2 receptors contribute to the analgesic effect of orientin, whereas KATP channels do not appear to be directly involved.
- 12 May 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (5) , e01995
In Vivo Evaluation of the Analgesic Effects of Orientin With Possible Underlying Mechanisms
Orientin is a water‐soluble flavonoid C‐glycoside present in various medicinal plants and known for its diverse pharmacological activities. The present study aimed to evaluate the acute antinociceptive effects of orientin and to investigate the involvement of adrenergic, opioidergic, cannabinoid systems, and ATP‐sensitive potassium channels in these effects. Orientin (50, 100, and 200 mg/kg, i.p.) was administered to mice. Central antinociceptive activity was assessed using the hot‐plate and tail‐immersion tests, while peripheral activity was evaluated using the acetic acid‐induced writhing test. To explore the underlying mechanisms, mice were pretreated with yohimbine (α2‐adrenoceptor antagonist), naloxone (μ‐opioid receptor antagonist), AM251 (CB1 receptor antagonist), AM630 (CB2 receptor antagonist), or glibenclamide (KATP channel blocker) prior to orientin administration. Orientin significantly reduced nociceptive responses in all experimental models at the tested doses. All antagonists except glibenclamide significantly reversed the spinal, supraspinal, and peripheral antinociceptive effects of orientin to varying degrees. These findings suggest that α2‐adrenoceptors, μ‐opioid receptors, and cannabinoid CB1 and CB2 receptors contribute to the analgesic effect of orientin, whereas KATP channels do not appear to be directly involved.
- 27 January 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 172, 109565
Novel thiadiazole derivatives: synthesis, in silico, in vitro and in vivo evaluation of analgesic and anti-inflammatory activities
- 27 January 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 172, 109565
Novel thiadiazole derivatives: synthesis, in silico, in vitro and in vivo evaluation of analgesic and anti-inflammatory activities
- 12 October 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 869, 138416
Ferulic acid possesses anxiolytic activity: evidence for the involvement of serotonergic and noradrenergic systems
- 12 October 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 869, 138416
Ferulic acid possesses anxiolytic activity: evidence for the involvement of serotonergic and noradrenergic systems
- Open Access
- 30 September 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (3) , 796-805
Anxiolytic-like effects of orientin in mice: behavioral and neurochemical investigations
Purpose: Orientin, a water-soluble flavonoid C-glycoside found in various medicinal plants, exhibits diverse pharmacological properties. This study aimed to evaluate its anxiolytic-like effects in mice and to explore the potential roles of adrenergic, serotonergic, and GABAergic neurotransmitter systems in mediating these effects. Materials and Methods: Orientin was administered intraperitoneally to mice at 20, 40, or 80 mg/kg. Anxiolytic-like effects were assessed using the light–dark box, elevated plus maze, hole-board, and open-field tests. For mechanism studies, separate groups received α₂-adrenergic antagonist yohimbine (5 mg/kg), 5-HT1A antagonist WAY-100635 (1 mg/kg), or GABAA antagonist flumazenil (3 mg/kg) prior to 20 mg/kg orientin. Results: Orientin at 20 mg/kg elicited significant anxiolytic-like effects in the hole-board, light–dark box, and open-field tests. The 40 mg/kg dose produced a significant effect only in the hole-board test, whereas the 80 mg/kg dose failed to elicit significant changes in any behavioral paradigm. The pronounced efficacy observed at 20 mg/kg suggests a bell-shaped dose–response profile. Pretreatment with α₂-adrenergic, 5-HT1A serotonergic, or GABAA receptor antagonists partially or completely attenuated the effects of orientin, with the degree of reversal varying among the behavioral assays. Conclusion: The present findings provide compelling evidence that orientin exerts anxiolytic-like effects, potentially mediated via α₂-adrenergic, 5-HT1A serotonergic, and GABAA receptor pathways.
- 30 September 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (3) , 796-805
Open AccessAnxiolytic-like effects of orientin in mice: behavioral and neurochemical investigations
Purpose: Orientin, a water-soluble flavonoid C-glycoside found in various medicinal plants, exhibits diverse pharmacological properties. This study aimed to evaluate its anxiolytic-like effects in mice and to explore the potential roles of adrenergic, serotonergic, and GABAergic neurotransmitter systems in mediating these effects. Materials and Methods: Orientin was administered intraperitoneally to mice at 20, 40, or 80 mg/kg. Anxiolytic-like effects were assessed using the light–dark box, elevated plus maze, hole-board, and open-field tests. For mechanism studies, separate groups received α₂-adrenergic antagonist yohimbine (5 mg/kg), 5-HT1A antagonist WAY-100635 (1 mg/kg), or GABAA antagonist flumazenil (3 mg/kg) prior to 20 mg/kg orientin. Results: Orientin at 20 mg/kg elicited significant anxiolytic-like effects in the hole-board, light–dark box, and open-field tests. The 40 mg/kg dose produced a significant effect only in the hole-board test, whereas the 80 mg/kg dose failed to elicit significant changes in any behavioral paradigm. The pronounced efficacy observed at 20 mg/kg suggests a bell-shaped dose–response profile. Pretreatment with α₂-adrenergic, 5-HT1A serotonergic, or GABAA receptor antagonists partially or completely attenuated the effects of orientin, with the degree of reversal varying among the behavioral assays. Conclusion: The present findings provide compelling evidence that orientin exerts anxiolytic-like effects, potentially mediated via α₂-adrenergic, 5-HT1A serotonergic, and GABAA receptor pathways.
- 31 December 2024
- Published by Walter de Gruyter GmbH in Zeitschrift für Naturforschung C
- Vol. 80 (9-10) , 563-571
In vivo evaluation of the antinociceptive effects of novel methylsulfonyl group-containing compounds
Pain management is among the problems that remain important today, and analgesic agents such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, tricyclic antidepressants, and anticonvulsants used in pain treatment cause various side effects. Therefore, new, safe, and highly effective drugs are needed. Synthesis of chemical molecules has begun to be preferred as a faster and easier method in new drug development processes. In this study, new compounds (3a–3k) containing the “methylsulfonyl group,” which have been shown to have potential inhibitory effects on cyclooxygenase (COX) enzymes responsible for the synthesis of inflammatory mediators, were synthesized. Central antinociceptive effect of the compounds was evaluated by hot-plate and tail-immersion tests, and the peripheral antinociceptive effect was evaluated by acetic acid-induced writhing test. 3a, 3b, 3d, 3e, 3f, 3g, 3h, 3i, 3j, and 3k (20 mg/kg) significantly increased the percentage of the maximum possible effect (MPE %) in the hot-plate test compared to the control group. 3a–3k (20 mg/kg) significantly increased MPE % in the tail-immersion test compared to the control group and significantly decreased the number of writhings in the acetic acid-induced writhing test. The results of this study indicate that the synthesized compounds containing methylsulfonyl groups have central and peripheral antinociceptive effects.
- 31 December 2024
- Published by Walter de Gruyter GmbH in Zeitschrift für Naturforschung C
- Vol. 80 (9-10) , 563-571
In vivo evaluation of the antinociceptive effects of novel methylsulfonyl group-containing compounds
Pain management is among the problems that remain important today, and analgesic agents such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, tricyclic antidepressants, and anticonvulsants used in pain treatment cause various side effects. Therefore, new, safe, and highly effective drugs are needed. Synthesis of chemical molecules has begun to be preferred as a faster and easier method in new drug development processes. In this study, new compounds (3a–3k) containing the “methylsulfonyl group,” which have been shown to have potential inhibitory effects on cyclooxygenase (COX) enzymes responsible for the synthesis of inflammatory mediators, were synthesized. Central antinociceptive effect of the compounds was evaluated by hot-plate and tail-immersion tests, and the peripheral antinociceptive effect was evaluated by acetic acid-induced writhing test. 3a, 3b, 3d, 3e, 3f, 3g, 3h, 3i, 3j, and 3k (20 mg/kg) significantly increased the percentage of the maximum possible effect (MPE %) in the hot-plate test compared to the control group. 3a–3k (20 mg/kg) significantly increased MPE % in the tail-immersion test compared to the control group and significantly decreased the number of writhings in the acetic acid-induced writhing test. The results of this study indicate that the synthesized compounds containing methylsulfonyl groups have central and peripheral antinociceptive effects.
- 23 September 2024
- Published by Academician Publishing
- p. 53-72
Farmakoloji Anabilim Dalı
Eczacılık Fakültesi Meslek Bilimleri Bölümü içerisinde yer alan Farmakoloji Anabilim Dalı; ilaçların kaynaklarını, kimyasal ve fiziksel özelliklerini, vücuda alınışlarını, ilaçların etkilerini, etki mekanizmalarını ve tedavide kullanımlarını incelemektedir. Özetle farmakoloji; “ilaç bilimi’’dir. İlaçlar, ilaç ürünleri, ilaç olabilecek kimyasal maddeler, doğal ürünler, rekombinasyon ürünleri, ilaç ile biyolojik veya fizyolojik sistemlerin etkileşmesini inceleyen farmakodinami ve ilacın vücuttaki yazgısı araştıran farmakokinetik farmakolojinin temel uğraş alanları arasındadır. Farmakoloji Anabilim Dalı hücre, hücre altı yapılar, biyoaktif moleküller, dokular ve organlar üzerinde in vitro veya deney hayvanı ve/veya insan üzerinde in vivo çalışmalar yaparak çalışmalarını yürütmektedir. The Department of Pharmacology, within the Division of Professional Pharmaceutical Sciences of the Faculty of Pharmacy, examines the sources, chemical and physical properties of drugs, their intake into the body, the effects of drugs, their mechanisms of action, and their use in treatment. In short, pharmacology is the “science of drugs." Drugs, drug products, chemical substances with medicinal potential, natural products, recombination products, pharmacodynamics, which examines the interaction between drugs and biological or physiological systems, and pharmacokinetics, which investigates the fate of drugs in the body, are among the basic areas of pharmacology. The Department of Pharmacology conducts in vitro studies on cells, subcellular structures, bioactive molecules, tissues, or organs, and in vivo studies on laboratory animals and/or humans.
- 23 September 2024
- Published by Academician Publishing
- p. 53-72
Farmakoloji Anabilim Dalı
Eczacılık Fakültesi Meslek Bilimleri Bölümü içerisinde yer alan Farmakoloji Anabilim Dalı; ilaçların kaynaklarını, kimyasal ve fiziksel özelliklerini, vücuda alınışlarını, ilaçların etkilerini, etki mekanizmalarını ve tedavide kullanımlarını incelemektedir. Özetle farmakoloji; “ilaç bilimi’’dir. İlaçlar, ilaç ürünleri, ilaç olabilecek kimyasal maddeler, doğal ürünler, rekombinasyon ürünleri, ilaç ile biyolojik veya fizyolojik sistemlerin etkileşmesini inceleyen farmakodinami ve ilacın vücuttaki yazgısı araştıran farmakokinetik farmakolojinin temel uğraş alanları arasındadır. Farmakoloji Anabilim Dalı hücre, hücre altı yapılar, biyoaktif moleküller, dokular ve organlar üzerinde in vitro veya deney hayvanı ve/veya insan üzerinde in vivo çalışmalar yaparak çalışmalarını yürütmektedir. The Department of Pharmacology, within the Division of Professional Pharmaceutical Sciences of the Faculty of Pharmacy, examines the sources, chemical and physical properties of drugs, their intake into the body, the effects of drugs, their mechanisms of action, and their use in treatment. In short, pharmacology is the “science of drugs." Drugs, drug products, chemical substances with medicinal potential, natural products, recombination products, pharmacodynamics, which examines the interaction between drugs and biological or physiological systems, and pharmacokinetics, which investigates the fate of drugs in the body, are among the basic areas of pharmacology. The Department of Pharmacology conducts in vitro studies on cells, subcellular structures, bioactive molecules, tissues, or organs, and in vivo studies on laboratory animals and/or humans.
- Open Access
- 15 September 2024
- Published by Holistence Publications
All Aspects of Celiac Disease and its Managements
Edited by Prof. Dr. Nurnehir Baltacı Bozkurt, Asst. Prof. Dr. Tuba Taşkan, and Asst. Prof. Dr. Hazal Eken, this book is a comprehensive study addressing celiac disease with a multidisciplinary approach. The work details the pathophysiology, diagnostic methods, and clinical findings of celiac disease, an autoimmune reaction to gluten in genetically predisposed individuals. The book emphasizes the systemic nature of the disease, affecting not only the gastrointestinal system but also neurological, dermatological, and hematological systems. Current treatment approaches, the importance of a gluten-free diet, and the challenges encountered while implementing this diet are examined. Furthermore, nutritional recommendations to improve the quality of life for celiac patients, alternative grain sources, and new developments in the food industry are discussed. The work serves as a resource enriched with current scientific data aiming to guide both health professionals and patients in disease management.
- 15 September 2024
- Published by Holistence Publications
Open AccessAll Aspects of Celiac Disease and its Managements
Edited by Prof. Dr. Nurnehir Baltacı Bozkurt, Asst. Prof. Dr. Tuba Taşkan, and Asst. Prof. Dr. Hazal Eken, this book is a comprehensive study addressing celiac disease with a multidisciplinary approach. The work details the pathophysiology, diagnostic methods, and clinical findings of celiac disease, an autoimmune reaction to gluten in genetically predisposed individuals. The book emphasizes the systemic nature of the disease, affecting not only the gastrointestinal system but also neurological, dermatological, and hematological systems. Current treatment approaches, the importance of a gluten-free diet, and the challenges encountered while implementing this diet are examined. Furthermore, nutritional recommendations to improve the quality of life for celiac patients, alternative grain sources, and new developments in the food industry are discussed. The work serves as a resource enriched with current scientific data aiming to guide both health professionals and patients in disease management.
- 22 April 2024
- Published by Elsevier in Neuropharmacology
- Vol. 253, 109961
Examination of the effects of vitexin and vitexin-loaded solid lipid nanoparticles on neuropathic pain and possible mechanisms of action
- 22 April 2024
- Published by Elsevier in Neuropharmacology
- Vol. 253, 109961
Examination of the effects of vitexin and vitexin-loaded solid lipid nanoparticles on neuropathic pain and possible mechanisms of action
- Open Access
- 1 January 2024
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 48 (2) , 6
İNSAN PAPİLLOMA VİRÜSÜ (HPV) TEDAVİSİNDE YENİ YAKLAŞIMLAR: AKTİF HEKSOZ İLİŞKİLİ BİLEŞİK (AHCC®)
Amaç: İnsan papilloma virüsü (HPV) alt tiplerine bağlı olarak cilt ve mukoza zarlarında siğil ve kanser oluşumuna sebep olabilen cinsel yolla bulaşan en yaygın viral enfeksiyon olması sebebi ile ciddi bir halk sağlığı problemi oluşturmaktadır. Günümüzde HPV tedavisinde hastalığın eradikasyonunu sağlamayan, sadece dışa doğru büyüyen siğillerin uzaklaştırılmasını ve semptomların iyileştirilmesini amaçlayan seçenekler mevcuttur. Bu tedavilerin dışında immün sistemi destekleyici çeşitli doğal ürünlerin kullanımının da HPV tedavisinde faydalı olabileceği gösterilmiştir. Mantar ekstraktlarının bağışıklık sistemi üzerindeki kesin etkileri tam olarak aydınlatılamamış olsa da uzun yıllardan beri dünyanın farklı bölgelerinde çeşitli sağlık sorunları için kullanılmaktadır. Bu derlemede bir mantar ekstratı olan AHCC®’nin HPV enfeksiyonu üzerindeki etkilerine odaklanılmıştır. Sonuç ve Tartışma: Yenilebilir bir mantar olan Lentinula edodes'in asetillenmiş α-1,4-glukanlar bakımından zenginleştirilmiş, standartlaştırılmış, kültürlenmiş bir özütü olan AHCC® sahip olduğu çeşitli farmakolojik etkileri nedeni ile HPV tedavisinde öne çıkan alternatif tedavi seçenekleri arasında yer almaktadır. Yapılan preklinik ve klinik çalışmalar, AHCC®’nin bağışıklık sistemini destekleyerek HPV tedavisi için umut veren yeni bir seçenek olabileceğini göstermektedir.
- 1 January 2024
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 48 (2) , 6
Open AccessİNSAN PAPİLLOMA VİRÜSÜ (HPV) TEDAVİSİNDE YENİ YAKLAŞIMLAR: AKTİF HEKSOZ İLİŞKİLİ BİLEŞİK (AHCC®)
Amaç: İnsan papilloma virüsü (HPV) alt tiplerine bağlı olarak cilt ve mukoza zarlarında siğil ve kanser oluşumuna sebep olabilen cinsel yolla bulaşan en yaygın viral enfeksiyon olması sebebi ile ciddi bir halk sağlığı problemi oluşturmaktadır. Günümüzde HPV tedavisinde hastalığın eradikasyonunu sağlamayan, sadece dışa doğru büyüyen siğillerin uzaklaştırılmasını ve semptomların iyileştirilmesini amaçlayan seçenekler mevcuttur. Bu tedavilerin dışında immün sistemi destekleyici çeşitli doğal ürünlerin kullanımının da HPV tedavisinde faydalı olabileceği gösterilmiştir. Mantar ekstraktlarının bağışıklık sistemi üzerindeki kesin etkileri tam olarak aydınlatılamamış olsa da uzun yıllardan beri dünyanın farklı bölgelerinde çeşitli sağlık sorunları için kullanılmaktadır. Bu derlemede bir mantar ekstratı olan AHCC®’nin HPV enfeksiyonu üzerindeki etkilerine odaklanılmıştır. Sonuç ve Tartışma: Yenilebilir bir mantar olan Lentinula edodes'in asetillenmiş α-1,4-glukanlar bakımından zenginleştirilmiş, standartlaştırılmış, kültürlenmiş bir özütü olan AHCC® sahip olduğu çeşitli farmakolojik etkileri nedeni ile HPV tedavisinde öne çıkan alternatif tedavi seçenekleri arasında yer almaktadır. Yapılan preklinik ve klinik çalışmalar, AHCC®’nin bağışıklık sistemini destekleyerek HPV tedavisi için umut veren yeni bir seçenek olabileceğini göstermektedir.
- Open Access
- 25 September 2019
- Published by Mersin Universitesi Tip Fakultesi Lokman Hekim Tip Tarihi ve Folklorik Tip Dergisi in Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi
- Vol. 9 (3) , 385-392
Peripheral Analgesic Effect and Possible Mechanisms of Ferulic Acid
Ferulic acid is a bioactive phenolic compound that is found intensely in plants used in traditional medicine such as Ferula assa-foetida L.. The analgesic effect of various medicinal plants has been associated with its constituent, ferulic acid. However, there are limited number of studies about mechanism of its analgesic action. The aim of this study was to evaluate the contribution of NO/cGMP/PKG/KATP pathway in peripheral analgesic effect of ferulic acid by acetic acid-induced (0.6 % acetic acid, i.p.) writhing test in mice. For this purpose, following the determination of the analgesic effect of ferulic acid at the doses of 20, 40, 80 and 160 mg/kg (p.o.), NO precursor 100 mg/kg L-arginine (i.p.), nitric oxide synthase inhibitor 30 mg/kg L-NAME (i.p.), guanylate cyclase inhibitor 20 mg/kg methylene blue (i.p.) and KATP channel blocker 10 mg/kg glibenclamide (i.p.) were administered separately prior to ferulic acid treatment at the dose effective for clarifying the mechanism of action. Reduction in the number of writhes was evaluated as peripheral analgesic activity. Ferulic acid significantly decreased the number of writhes at the doses of 40, 80 and 160 mg/kg. 80 mg/kg ferulic acid and 100 mg/kg acetyl salicylic acid demonstrated similar efficacy. L-arginine and methylene blue relatively reversed the reduction in the number of writhes caused by ferulic acid at 80 mg/kg, whereas L-NAME did not. Glibenclamide pre-treatment significantly inhibited analgesic effect induced by ferulic acid. The results of the study indicate that ferulic acid has peripheral analgesic activity and it is mediated predominantly by activation of KATP channels and partially by cGMP. In conclusion, findings of this study demonstrate that ferulic acid may provide an advantage in KATP channel-targeted management of pain.
- 25 September 2019
- Published by Mersin Universitesi Tip Fakultesi Lokman Hekim Tip Tarihi ve Folklorik Tip Dergisi in Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi
- Vol. 9 (3) , 385-392
Open AccessPeripheral Analgesic Effect and Possible Mechanisms of Ferulic Acid
Ferulic acid is a bioactive phenolic compound that is found intensely in plants used in traditional medicine such as Ferula assa-foetida L.. The analgesic effect of various medicinal plants has been associated with its constituent, ferulic acid. However, there are limited number of studies about mechanism of its analgesic action. The aim of this study was to evaluate the contribution of NO/cGMP/PKG/KATP pathway in peripheral analgesic effect of ferulic acid by acetic acid-induced (0.6 % acetic acid, i.p.) writhing test in mice. For this purpose, following the determination of the analgesic effect of ferulic acid at the doses of 20, 40, 80 and 160 mg/kg (p.o.), NO precursor 100 mg/kg L-arginine (i.p.), nitric oxide synthase inhibitor 30 mg/kg L-NAME (i.p.), guanylate cyclase inhibitor 20 mg/kg methylene blue (i.p.) and KATP channel blocker 10 mg/kg glibenclamide (i.p.) were administered separately prior to ferulic acid treatment at the dose effective for clarifying the mechanism of action. Reduction in the number of writhes was evaluated as peripheral analgesic activity. Ferulic acid significantly decreased the number of writhes at the doses of 40, 80 and 160 mg/kg. 80 mg/kg ferulic acid and 100 mg/kg acetyl salicylic acid demonstrated similar efficacy. L-arginine and methylene blue relatively reversed the reduction in the number of writhes caused by ferulic acid at 80 mg/kg, whereas L-NAME did not. Glibenclamide pre-treatment significantly inhibited analgesic effect induced by ferulic acid. The results of the study indicate that ferulic acid has peripheral analgesic activity and it is mediated predominantly by activation of KATP channels and partially by cGMP. In conclusion, findings of this study demonstrate that ferulic acid may provide an advantage in KATP channel-targeted management of pain.